OBJECTIVE: Human immunodeficiency virus (HIV) infection and antiretroviral treatment are associated with metabolic and cardiovascular complications that resemble metabolic syndrome (MetS) and potentially increase the risk of diabetes and cardiovascular disease in this population. The purpose of this study was to determine the prevalence of MetS and its individual components among Hispanics living with HIV in Puerto Rico. METHODS: Data from 909 clinical records were extracted and the prevalence of MetS determined using the NCEP-ATPIII criteria. Fisher's exact test was used to detect sex differences, and logistic regression to examine the effect of age, sex, smoking, years of HIV infection, antiretroviral therapy, and Hepatitis C coinfection. RESULTS: The prevalence of MetS in our study group (35.4%) was higher than previously reported in the United States, but not higher than in the general population in Puerto Rico. Females had a higher prevalence of MetS (44.2%) than males (30.5%); mostly explained by high body mass index and waist circumference. Age and sex were associated with the presence of MetS. CONCLUSION: Understanding ethnic and sex differences in the prevalence of metabolic risk factors is essential for the implementation of specific targeted interventions to prevent subsequent vascular morbidity and mortality in this population.
OBJECTIVE:Human immunodeficiency virus (HIV) infection and antiretroviral treatment are associated with metabolic and cardiovascular complications that resemble metabolic syndrome (MetS) and potentially increase the risk of diabetes and cardiovascular disease in this population. The purpose of this study was to determine the prevalence of MetS and its individual components among Hispanics living with HIV in Puerto Rico. METHODS: Data from 909 clinical records were extracted and the prevalence of MetS determined using the NCEP-ATPIII criteria. Fisher's exact test was used to detect sex differences, and logistic regression to examine the effect of age, sex, smoking, years of HIV infection, antiretroviral therapy, and Hepatitis C coinfection. RESULTS: The prevalence of MetS in our study group (35.4%) was higher than previously reported in the United States, but not higher than in the general population in Puerto Rico. Females had a higher prevalence of MetS (44.2%) than males (30.5%); mostly explained by high body mass index and waist circumference. Age and sex were associated with the presence of MetS. CONCLUSION: Understanding ethnic and sex differences in the prevalence of metabolic risk factors is essential for the implementation of specific targeted interventions to prevent subsequent vascular morbidity and mortality in this population.
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Cardiol Rev Date: 2005 Nov-Dec Impact factor: 2.644
Authors: Carlos Jericó; Hernando Knobel; Milagro Montero; Jordi Ordoñez-Llanos; Ana Guelar; Juan L Gimeno; Pere Saballs; Jose L López-Colomés; Juan Pedro-Botet Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: Valerianna Amorosa; Marie Synnestvedt; Robert Gross; Harvey Friedman; Rob Roy MacGregor; Debie Gudonis; Ian Frank; Pablo Tebas Journal: J Acquir Immune Defic Syndr Date: 2005-08-15 Impact factor: 3.731
Authors: Jeanne Salyer; Debra E Lyon; Jane Settle; R K Elswick; Dwight Rackley Journal: J Assoc Nurses AIDS Care Date: 2006 May-Jun Impact factor: 1.354
Authors: Farah A Ramírez-Marrero; Jorge L Santana-Bagur; Michael J Joyner; Jorge Rodríguez-Zayas; Walter Frontera Journal: P R Health Sci J Date: 2014-12 Impact factor: 0.705
Authors: Charles Muiruri; Chris T Longenecker; Eric G Meissner; Nwora Lance Okeke; April C Pettit; Kevin Thomas; Eric Velazquez; Gerald S Bloomfield Journal: Prog Cardiovasc Dis Date: 2020-02-11 Impact factor: 8.194
Authors: Lívia D Akl; Ana L R Valadares; Monica Jacques de Moraes; Aarão M Pinto-Neto; Bianca Lagrutta; Lúcia Costa-Paiva Journal: Braz J Infect Dis Date: 2017-03-08 Impact factor: 3.257